Pharmaceutically acceptable salts of pyrrolo-nitrogenous heterocyclic derivatives, preparation method and medical use thereof are disclosed. More specifically, pharmaceutically acceptable salts of ( R,Z )-2-(5-fluoro-2-oxo-1,2-dihydro-indol-3-methylene)-5-(2-hydroxy-3-morpholinyl-4-yl-propyl)-3-methyl-5,6,7,8-tetrahydro-1 H- pyrrolo[3,2- c ]azepin-4-one presented by formula (I), the preparation method and the use thereof as therapeutic agents, especially as protein kinase inhibitors, are disclosed.피롤로-질소 헤테로사이클릭 유도체의 약학적 염, 그의 제조방법 및 의학적 용도가 개시된다. 보다 구체적으로, 하기 화학식 (I)의 (R,Z)-2-(5-플루오로-2-옥소-1,2-디하이드로-인돌-3-일리덴메틸)-5-(2-하이드록시-3-모르폴린-4-일-프로필)-3-메틸-5,6,7,8-테트라하이드로-1H-피롤로[3,2-c]아제핀-4-온의 약학적으로 허용가능한 염, 그의 제조방법 및 치료제, 특히 단백질 키나제 저해제로서의 그의 용도가 개시된다:.
